Editorial: Save the Stem Cells
By The Daily Californian,
The Daily Californian
| 10. 04. 2005
UC likes living on the technological edge. So when California allocated funds for stem cell research as mandated by Proposition 71, UC was one of the first that stood to benefit. With our help, such research could lead to breakthrough drugs for cancer and congenital diseases. But in its haste to see some returns on this endeavor, the state legislature may make a big mistake by adopting provisions of the 1980 Bayh-Dole Patent and Trademark Act.
This federal law was designed to give universities more leeway in taking lab work to market. The act allowed universities to patent federally funded research and license the results to companies, helping to develop their findings for profit.
Bayh-Dohl didn't exactly break new ground: Universities have always had close relationships with related industries. Professors at some universities even get a day off per week to consult with them.
But Bayh-Dole benefits industry more than it helps universities. The act has changed the way universities conduct research, giving rise to complex corporate relationships. Even now, the stem-cell board that doles out funds cannot give UC...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Elizabeth Chuck, NBC News | 07.09.2024
A Netflix docuseries has put a spotlight on the unregulated world of sperm donation, particularly the lack of stopgap measures that might prevent donors who have been banned by one country from simply going elsewhere to donate more.
Released earlier...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...